FR2973376B1 - Derives utiles dans le traitement ou la prevention de tumeurs osseuses - Google Patents

Derives utiles dans le traitement ou la prevention de tumeurs osseuses

Info

Publication number
FR2973376B1
FR2973376B1 FR1152545A FR1152545A FR2973376B1 FR 2973376 B1 FR2973376 B1 FR 2973376B1 FR 1152545 A FR1152545 A FR 1152545A FR 1152545 A FR1152545 A FR 1152545A FR 2973376 B1 FR2973376 B1 FR 2973376B1
Authority
FR
France
Prior art keywords
prevention
treatment
derivatives useful
bone tumors
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1152545A
Other languages
English (en)
Other versions
FR2973376A1 (fr
Inventor
Maxim Egorov
Bot Ronan Le
Fabien Petit
Olivier Grovel
Yves Francois Pouchus
Marieke Vansteelandt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ATLANTHERA, FR
Universite de Nantes
Original Assignee
Universite de Nantes
Atlanthera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Nantes, Atlanthera SAS filed Critical Universite de Nantes
Priority to FR1152545A priority Critical patent/FR2973376B1/fr
Priority to PCT/EP2012/055563 priority patent/WO2012130906A1/fr
Publication of FR2973376A1 publication Critical patent/FR2973376A1/fr
Application granted granted Critical
Publication of FR2973376B1 publication Critical patent/FR2973376B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
FR1152545A 2011-03-28 2011-03-28 Derives utiles dans le traitement ou la prevention de tumeurs osseuses Active FR2973376B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1152545A FR2973376B1 (fr) 2011-03-28 2011-03-28 Derives utiles dans le traitement ou la prevention de tumeurs osseuses
PCT/EP2012/055563 WO2012130906A1 (fr) 2011-03-28 2012-03-28 Derives utiles dans le traitement ou la prevention de tumeurs osseuses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1152545A FR2973376B1 (fr) 2011-03-28 2011-03-28 Derives utiles dans le traitement ou la prevention de tumeurs osseuses

Publications (2)

Publication Number Publication Date
FR2973376A1 FR2973376A1 (fr) 2012-10-05
FR2973376B1 true FR2973376B1 (fr) 2013-05-10

Family

ID=44063217

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1152545A Active FR2973376B1 (fr) 2011-03-28 2011-03-28 Derives utiles dans le traitement ou la prevention de tumeurs osseuses

Country Status (2)

Country Link
FR (1) FR2973376B1 (fr)
WO (1) WO2012130906A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201636342A (zh) 2014-12-19 2016-10-16 武田藥品工業有限公司 煙黴醇衍生物
CN105622593B (zh) * 2016-02-25 2018-06-26 中国农业科学院蜜蜂研究所 一种烟曲霉素的提取方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0415294A3 (en) * 1989-08-31 1991-06-12 Takeda Chemical Industries, Ltd. Cyclohexanol derivatives, production and use thereof
TW282399B (fr) * 1990-05-25 1996-08-01 Takeda Pharm Industry Co Ltd
WO1998056372A1 (fr) * 1997-06-09 1998-12-17 Massachusetts Institute Of Technology Inhibiteurs de la methionine aminopeptidase de type 2 et leurs utilisations
US7087768B2 (en) * 2001-09-27 2006-08-08 Equispharm Co., Ltd. Fumagillol derivatives and preparing method thereof
KR100451485B1 (ko) * 2002-03-28 2004-10-06 주식회사종근당 푸마질롤 유도체 또는 그 염의 포접 화합물, 및 이를포함하는 약제학적 조성물
FR2926080B1 (fr) 2008-01-03 2010-04-02 Univ Nantes Procede de synthese de derives d'acide hydroxy-bisphosphonique
AU2011239414A1 (en) * 2010-04-15 2012-11-08 The Washington University Prodrug compositions, prodrug nanoparticles, and methods of use thereof

Also Published As

Publication number Publication date
WO2012130906A1 (fr) 2012-10-04
FR2973376A1 (fr) 2012-10-05

Similar Documents

Publication Publication Date Title
SG11202012656WA (en) Heterocyclic compounds useful in the treatment of disease
CO6930321A2 (es) Curación de tejidos
EP2890440A4 (fr) Dispositifs et procédés pour le traitement d'une maladie vasculaire
BR112013030983A2 (pt) método de tratamento ou prevenção de arritmia cardíaca
CO6791606A2 (es) Composiciones y métodos para el tratamiento en aplicaciones clínicas de amplio espectro, no diferenciadas o combinadas
BR112013013898A2 (pt) compostos de pirimidinona para o uso no tratamento de doenças ou condições mediadas por lp-pla2
ZA201408056B (en) Compositions and methods for the treatment of mucositis
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
HK1201045A1 (en) Compositions and methods for the diagnosis and treatment of tumor
FR2991327B1 (fr) Procede de lyophilisation d'hemoglobine d'annelides
BR112014025507A2 (pt) formulação vesicular e método de tratamento
BR112014009456A2 (pt) uso de melatonina para o tratamento e/ou prevenção de mucosite
HK1212255A1 (en) Artemisinin and its derivatives for use in the treatment of kidney disease
FR2934267B1 (fr) Derives aminophosphiniques utiles dans le traitement de la douleur
FR2999428B1 (fr) Chitine ou derives de chitine pour utilisation dans la prevention et/ou le traitement de parasitoses
SMT201600474B (it) Procedimento per la preparazione di pemetrexed e suo sale di lisina
BR112013014915A2 (pt) composição curativa e métodos de tratamento
FR3000491B1 (fr) Composes utilisables dans le traitement des infections mycobacteriennes
FR2969616B1 (fr) Procede de preparation de complexes carbeniques de platine
BR112014032290A2 (pt) composições e métodos para tratar ou prevenir infecção de pneumovírus e doenças associadas.
HK1216721A1 (zh) 治療肝臟疾病或病狀的用途和方法
GB2515440B (en) Vesicular Formulations for use in the treatment of Rosacea
FR2993564B1 (fr) Derives d'imidazopyridine utiles dans le traitement du diabete
ITRM20120530A1 (it) Compounds for use in the treatment of parasitic diseases
EP2729155A4 (fr) Méthodes de traitement ou de prévention d'une maladie rhumatismale

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

TQ Partial transmission of property

Owner name: NANTES UNIVERSITE, FR

Effective date: 20230914

Owner name: ATLANTHERA, FR

Effective date: 20230914

PLFP Fee payment

Year of fee payment: 14